23Jan
Blog: Cooley's 2019 Life Sciences M&A Year in Review
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in...
By:
Cooley LLP
Related
The H-1B Specialty Occupation Visa allows companies to sponsor foreign national workers for jobs tha...
Read More >
On January 12, 2020, the United States Department of Labor ("USDOL") Wage and Hour Division announce...
Read More >
Welcome to your weekly update from the Allen & Overy Pensions team, bringing you up to speed on the ...
Read More >
The ECB was even more aggressive than expected in its moves to “head off a downturn before it gaine...
Read More >
Despite the difficulties brought on by the Covid-19 pandemic, November 2020 has been a transformatio...
Read More >
On November 22, 2019, the U.S. Court of Appeals for the First Circuit in Sun Capital Partners III, L...
Read More >